Benzinga

Benzinga

Benzinga

domenica, agosto 30

Propanc Biopharma Inc

PPCBNASDAQ
Trade with Public
Trade with Public
$1.35
-0.88-39.46%
In chiusura: Aug 28, 5:00 PM EST
$1.34
-0.01-0.74%
Post-mercato: Aug 28, 7:59 PM EST
PanoramicaNotiziePrevisioni utiliDati finanziariSentimentConfrontaRapporto azionario

Propanc Biopharma Financials

Propanc Biopharma (PPCB) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Propanc Biopharma Q3 EPS $(0.28) Up From $(12.50) YoY

Propanc Biopharma (NASDAQ:PPCB) reported quarterly losses of $(0.28) per share. This is a 97.76 percent increase over losses of $(12.50) per share from the same period last year.
Benzinga Newsdesk

PRO
Propanc Biopharma Q2 EPS $(0.30) Up From $(32.23) YoY

Propanc Biopharma (NASDAQ:PPCB) reported quarterly losses of $(0.30) per share. This is a 99.07 percent increase over losses of $(32.23) per share from the same period last year.
Benzinga Newsdesk

PRO
Propanc Biopharma Q1 2025 EPS $(0.39) Up From $(35.97) YoY

Benzinga Newsdesk

Crude Oil Moves Higher; US Homebuilder Sentiment Declines In August

Avi Kapoor

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved